Pronunciation: la-BET-a-loel
Mechanism of action: Labetalol ballicule
Visual mnemonic: Labetalol mascot
“Label all Train dates”
LOL hat → beta blocker
What it isCombined alpha-1 and non-selective beta blocker; hypertensive emergency and hypertension in pregnancy.
Why this oneIV titratability plus a pregnancy safety record make it a standard parenteral option in preeclampsia.
What limits itOrthostatic hypotension, and the beta blockade limits it in asthma. Hepatotoxicity is rare but reported.
Molecular structure: Labetalol
FDA-approved for
FDA label
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
| Hypertension | adult | 100 mg BID | 200-400 mg BID | 1,200-2,400 mg/day (severe hypertension) |
Titration After 2-3 days, may titrate in 100 mg BID increments every 2-3 days (increments not to exceed 200 mg BID)
Renal Undefined
Hepatic Undefined
Instructions
- Dosage must be individualized; may split total daily dose to TID to improve tolerability
- Additive effect when a diuretic is added—may require dose adjustment
Available strengths
- tab 100, 200, 300, 400 mg
- inj 5 mg/mL
Contraindications
- Bronchial asthma / history of obstructive airway disease
- Overt cardiac failure
- Greater-than-first-degree heart block
- Cardiogenic shock
- Severe bradycardia; other conditions with severe/prolonged hypotension
Cautions
- Hepatotoxicity (rare, some fatal)
- Exacerbation of ischemic heart disease on abrupt withdrawal
- Bronchospasm
- Heart failure/bradycardia
- Masking of hypoglycemia/thyrotoxicosis
- Orthostatic hypotension
Adverse reactions
- Dizziness
- Fatigue
- Nausea
- Nasal congestion
- Headache
Pregnancy Pregnancy Category C; use only if potential benefit justifies potential fetal risk
Lactation Undefined
Cost
Labetalol (TRANDATE)
What pharmacies pay · NADAC 9/30/26
| Strength | | #/mo | generic $ | CostPlus |
|---|
| 100 mg | tab | 60 BID | $5.04/mo | offered |
| 200 mg | tab | 60 BID | $8.37/mo | offered |
| 300 mg | tab | 60 BID | $12.88/mo | offered |
| 400 mg | tab | 60 BID | $93.15/mo | offered |
| 5 mg/mL | inj | per unit | $0.19/mL | not offered |
Generic entry1998
Principal riskOrthostatic hypotension; the preferred agent in pregnancy
Classes and tags
Clinical profile
Therapeutic safety burden2 / 4
Overdose danger3 / 4
Weight-gain liability1 / 4
Sedation liability1 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4
Legacy pregnancy categoryC
Defining liabilityBradycardia, hypotension and bronchospasm; overdose may cause conduction block or cardiogenic shock.
Open Labetalol in the interactive console ↗
Memory aids: interaction avatars
Box: minimal PK interactions
Open Labetalol in the interactive console ↗